The decline of NAD + with age results from three converging factors: (1) increased activity of CD38, a NADase whose expression increases with age-related chronic inflammation (inflammaging), (2) reduced biosynthesis via the NAMPT (nicotinamide phosphoribosyltransferase) and NMN pathways, and (3) increased demand for NAD+ by PARP-1 to repair increasing oxidative DNA damage
Prioritise your circadian rhythm Your body's internal clock becomes more fragile during perimenopause, so supporting it with consistent daily cues is one of the most effective things you can do
Mechanism of Action Differences Understanding how BPC-157 and TB-500 promote healing reveals why researchers often consider them complementary rather than interchangeable
Albiglutide was approved by the US FDA and the EMA in 2014
The frequency of peptide therapy depends on the specific peptide and your treatment goals
men should seek participation in a registered clinical trial via NIHR Be Part of Research, or discuss currently NICE-approved treatments such as semaglutide or tirzepatide with their GP